Brain Implants Market to Grow with a CAGR of 10.59% through 2031
Growing adoption of brain implants to get quick relief from chronic pain, resulting in the high growth of the Global Brain Implants Market by 2031.
According to
TechSci Research report, “Global Brain
Implants Market By Product Type (Deep Brain Stimulators, Spinal Cord
Stimulators, Vagus Nerve Stimulators) By Application (Chronic Pain, Epilepsy,
Parkinson’s Disease, Depression, Essential Tremor, Alzheimer’s Disease) By End
User (Hospitals & Clinics, Ambulatory Surgery Centers, Others) By Region,
Competition Forecast & Opportunities, 2031”, the Global Brain Implants Market will grow from USD 6.98 Billion in 2025 to USD 12.77 Billion by 2031 at a 10.59% CAGR.
Introduction of technologically advanced brain implants, such as MIT's "circulatronics" microscopic wireless bioelectronics, has revolutionized treatment procedures by enabling self-implantation via bloodstream injection without surgery, crossing the blood-brain barrier intact, and providing precise neuromodulation for inflammation in neurological diseases like Alzheimer’s and chronic pain. AI-powered closed-loop deep brain stimulation (aDBS) systems, demonstrated in clinical trials for Parkinson’s patients, adapt stimulation in real-time to reduce symptoms by up to 50%, enhancing recovery rates and long-term symptom management beyond traditional fixed-output devices. Wireless transmission, AI-enhanced signal processing, microelectrode arrays, and MRI-compatible implants from companies like Medtronic, LivaNova, and Aleva Neurotherapeutics improve patient comfort, reduce invasiveness, and support remote programming via telemedicine, driving higher adoption for epilepsy, depression, and movement disorders.
The increasing inclination towards these superior treatment options stems from proven clinical outcomes, including slowed cognitive decline in Alzheimer’s trials, restored cognitive abilities post-traumatic brain injury via tailored DBS, and expanded applications in mental health with reduced medication dependency. Patients and physicians favor minimally invasive devices offering higher success rates, less pain, and sustained efficacy in managing geriatric-prevalent conditions like Parkinson’s and epilepsy, bolstered by regulatory approvals for breakthrough technologies and favorable reimbursement frameworks.
The onset of COVID-19 imposed complete lockdowns, shutting down manufacturing units worldwide and disrupting supply chains, which interrupted production and reduced implant availability globally. Economic downturns in multiple countries further hindered market access and elective neurosurgeries, exacerbating delays in patient treatments for neurological disorders.
Post-lockdown recovery has accelerated with stabilized supply chains, heightened demand for advanced implants amid rising post-COVID neuropathic pain prevalence (estimated at 24.4% in affected patients), and resumed clinical trials. Innovations like non-surgical circulatronics and AI-integrated systems, alongside global manufacturer expansions into regions like Asia-Pacific, have propelled significant market resurgence and adoption momentum as of late 2025.
Browse over XX market data Figures
spread through 110 Pages and an in-depth TOC on "Global Brain
Implants Market"
https://www.techsciresearch.com/report/brain-implants-market/7304.html
The global brain implants market is segmented by product type, application, end user, and region. By product type, the key categories include deep brain stimulators (DBS), spinal cord stimulators (SCS), and vagus nerve stimulators (VNS), with DBS accounting for the largest share of around 38% due to its effectiveness in treating Parkinson’s disease and other movement disorders. Based on application, the market covers chronic pain, epilepsy, Parkinson’s disease, depression, essential tremor, and Alzheimer’s disease, with chronic pain treatment holding the leading position. By end user, hospitals & clinics dominate the market owing to the availability of advanced neurosurgical equipment and expertise, followed by ambulatory surgery centers and neurology clinics.
Regionally, North America leads the market due to the high prevalence of neurological disorders, well-established healthcare infrastructure, and strong R&D investments, followed by Europe. The Asia-Pacific region is expected to witness the fastest growth over the forecast period due to expanding access to healthcare facilities, growing geriatric population, and increased awareness of neurological treatment options. Key market participants include Medtronic Plc., Boston Scientific Corporation, Abbott (St. Jude Medical), NeuroPace Inc., LivaNova PLC, Nevro Corporation, Synchron Inc., Aleva Neurotherapeutics SA, Renishaw Plc, Synapse Biomedical Inc., NDI Medical LLC, Functional Neuromodulation Ltd., Terumo Corporation, and Beijing PINS Medical Co. Ltd. These companies are focusing on extensive R&D activities including clinical validations of new implant technologies, miniaturized devices, and wireless neuromodulation systems. In addition, strategic alliances, partnerships, and mergers remain common competitive strategies.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7304
Customers
can also request for 10% free customization on this report.
“The deep brain stimulators segment is expected to dominate the market
for brain implants during the forecast period as it finds application in
treatment of neurological disorders such as obsessive-compulsive disorder,
Parkinson’s diseases, dystonia, essential tremor, epilepsy, and Alzheimer’s
disease. Growing awareness
about neurological movement disorder treatment among patients is anticipated to
trigger the growth of this market.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“Global Brain Implants Market By Product Type (Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators) By Application (Chronic Pain, Epilepsy, Parkinson’s Disease, Depression, Essential Tremor, Alzheimer’s Disease) By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others) By Region, Competition Forecast & Opportunities, 2021-2031F”, has evaluated the future growth potential of global brain
implants and provides statistics & information on market size, structure
and future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Brain Implants.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]